Abstract
Massive elevations of serum creatine kinase (CK) can occur in a significant number of patients treated with neuroleptics in the absence of neuroleptic malignant syndrome (NMS). We report two cases of CK-elevations associated with quetiapine treatment, which disappeared after drug discontinuation. To our knowledge, case number one is the first case of quetiapine-induced CK elevation in a neuroleptic-naïve patient. We thus suggest CK assessment when myalgia occurs with neuroleptic treatment.
| Original language | English |
|---|---|
| Journal | Pharmacopsychiatry |
| Volume | 39 |
| Issue number | 1 |
| Pages (from-to) | 39-40 |
| Number of pages | 2 |
| ISSN | 0176-3679 |
| DOIs | |
| Publication status | Published - 01.2006 |
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)